This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Jun;75(6):495-500.

doi: 10.1016/j.clpt.2004.01.011.

"Irinogenetics" and UGT1A: from genotypes to haplotypes

Federico Innocenti¹, Mark J Ratain

Affiliations

PMID: 15179404
DOI: 10.1016/j.clpt.2004.01.011

Review

"Irinogenetics" and UGT1A: from genotypes to haplotypes

Federico Innocenti et al. Clin Pharmacol Ther. 2004 Jun.

. 2004 Jun;75(6):495-500.

doi: 10.1016/j.clpt.2004.01.011.

Authors

Federico Innocenti¹, Mark J Ratain

Affiliation

¹ Department of Medicine, Committee on Clinical Pharmacology and Pharmacogenomics, Cancer Research Center, University of Chicago, IL 60637, USA.

PMID: 15179404
DOI: 10.1016/j.clpt.2004.01.011

No abstract available

PubMed Disclaimer

Comment on

UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer.
Sai K, Saeki M, Saito Y, Ozawa S, Katori N, Jinno H, Hasegawa R, Kaniwa N, Sawada J, Komamura K, Ueno K, Kamakura S, Kitakaze M, Kitamura Y, Kamatani N, Minami H, Ohtsu A, Shirao K, Yoshida T, Saijo N. Sai K, et al. Clin Pharmacol Ther. 2004 Jun;75(6):501-15. doi: 10.1016/j.clpt.2004.01.010. Clin Pharmacol Ther. 2004. PMID: 15179405

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

U01 GM61393/GM/NIGMS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley